Загрузка...
Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
Treatment of FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML) remains a challenge despite the development of novel FLT3-directed tyrosine kinase inhibitors (TKI); the relapse rate is still high even after allogeneic stem cell transplantation....
Сохранить в:
Главные авторы: | , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
MDPI AG
2020-11-01
|
Серии: | Cells |
Предметы: | |
Online-ссылка: | https://www.mdpi.com/2073-4409/9/11/2493 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|